Latest posts
-
AI in Drug Discovery: Accelerating the Path to Clinical Trials
Traditionally, bringing a new drug to market takes over a decade and billions of dollars, with a high failure rate in the early stages. Artificial Intelligence is flipping this script by analyzing molecular structures and biological data at speeds human researchers cannot match. AI contributes to the pipeline by: